ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2021, Vol. 30 ›› Issue (4): 357-361.DOI: 10.3969/j.issn.1006298X.2021.04.012

• • 上一篇    下一篇

膜性肾病相关靶抗原及自身抗体的研究进展

  

  • 出版日期:2021-08-28 发布日期:2021-08-17

Advances in target antigens and autoantibodies associated with membranous nephropathy

  • Online:2021-08-28 Published:2021-08-17

摘要: 膜性肾病(MN)是一类较常见的由免疫复合物介导的肾小球疾病,原位免疫复合物的沉积可能是其重要的发病机制之一。对MN相关抗原及相应自身抗体的识别鉴定及临床关联的研究是该领域研究的重要组成。迄今为止,以M型磷脂酶A2受体(PLA2R)和1型血小板反应蛋白7A域(THSD7A)为代表的一系列靶抗原被相继发现,这是数十年来连续不断的研究成果,得益于技术的发展,对于未知靶抗原的探索能够更进一步。特异性抗原相关的或不同水平自身抗体相关的MN患者具有不同的临床表现和预后。研究提示,不同的靶抗原可以作为MN的分类标准,为诊治提供依据,具有一定的临床意义。


关键词: 膜性肾病, 抗原, 自身抗体

Abstract: Membranous nephropathy (MN) is a common glomerular disease mediated by immune complexes(IC), and in situ IC deposit may be one of its major pathogenesis. The antigens and autoantibodies of MN and their significance of clinical are important parts of this field. A series of target antigens represented by Mtype phospholipase A2 receptor (PLA2R) and type 1 thrombospondin 7A domain (THSD7A) have been found, which is a continuous research achievement for decades. Due to the development of technology, the exploration of unknown target antigens can go further. Clinical manifestations and prognosis varying as different antigens or autoantibody titers of MN patients. Target antigens can be used as the classification of MN, which provides a basis for diagnosis and treatment,has a certain clinical significance.


Key words: membranous nephropathy, antigen, autoantibody